#National Comprehensive Cancer Network

The NCCN updated its guidelines for genetic testing for colorectal cancer patients; increased testing can reduce health disparities.

The levels of prostate-specific antigen in the blood can indicate further testing is needed to screen for cancer.

“I am living proof that early detection can save lives,” Tigerlily CEO Maimah Karmo said at the NCCN cancer policy summit.

A new tool helps oncologists predict which meds might lead to dangerous interactions and adverse effects in their older cancer patients.

Study: Most online pharmacies selling the chronic myeloid leukemia therapy imatinib are uncertified and could be operating unsafely.

Breast cancer experts recommend annual mammograms for all average-risk women over 40, plus screenings versus diagnostic tests and more.

The ELEVATE program enables access to high-quality smoking cessation care while minimizing costs and burden, finds a new study.

Rates of breast cancer survivors receiving annual mammograms dropped 1.5% per year from 2009 to 2016—and that’s before COVID-19 shutdowns.

A Canadian study finds an immediate cancer diagnosis decrease of 34% in March 2020, followed by a slow and incomplete recovery.

Groups sign letter detailing urgent need to regain lost ground on prevention and early detection and to accelerate cancer research.

The largest peer-reviewed study of the Pfizer-BioNTech COVID vaccine in cancer patients finds no more, and no different, side effects.

The National Comprehensive Cancer Network’s free resource helps cervical cancer patients know what to expect and participate in decisions.

National Comprehensive Cancer Network’s new patient guide covers effective tools for preventing and early detection of colorectal cancer.

People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.

Basal cell skin cancer is widespread, preventable, and easily-cured cancer but a rare subset requires more aggressive treatment.

New patient/caregiver resource from the National Comprehensive Cancer Network focuses on small cell lung cancer, an aggressive cancer.